↓ Skip to main content

PLOS

Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB

Overview of attention for article published in PLOS ONE, November 2012
Altmetric Badge

Mentioned by

twitter
1 X user
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
34 Mendeley
Title
Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB
Published in
PLOS ONE, November 2012
DOI 10.1371/journal.pone.0048832
Pubmed ID
Authors

Hao Ying, Yuhao Zhang, Xin Zhou, Xiying Qu, Pengfei Wang, Sijie Liu, Daru Lu, Huanzhang Zhu

Abstract

Histone deacetylase (HDAC) inhibitors present an exciting new approach to activate HIV production from latently infected cells to potentially enhance elimination of these cells and achieve a cure. M344, a novel HDAC inhibitor, shows robust activity in a variety of cancer cells and relatively low toxicity compared to trichostatin A (TSA). However, little is known about the effects and action mechanism of M344 in inducing HIV expression in latently infected cells.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Canada 1 3%
Unknown 32 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 24%
Researcher 7 21%
Student > Bachelor 4 12%
Student > Doctoral Student 2 6%
Student > Master 2 6%
Other 1 3%
Unknown 10 29%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 18%
Medicine and Dentistry 5 15%
Biochemistry, Genetics and Molecular Biology 4 12%
Immunology and Microbiology 4 12%
Chemistry 3 9%
Other 2 6%
Unknown 10 29%